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Background: The impaired adipogenic potential is a hallmark of preadipocyte senescence.
Results: Senescent preadipocytes treated with advanced glycation end products (AGEs) resumed adipogenesis in vitro and
ex vivo.
Conclusion: AGE-induced expression of the receptor for AGEs (RAGE) and AGE-RAGE-dependent inhibition of p53 function
restore adipogenesis in senescent preadipocytes.
Significance: Glycated proteins could participate in aging-impaired adipose development.
The impaired adipogenic potential of senescent preadipocytes is a hallmark of adipose aging and aging-related adipose
dysfunction. Although advanced glycation end products (AGEs)
derived from both foods and endogenous nonenzymatic glycation and AGE-associated signaling pathways are known to play a
key role in aging and its related diseases, the role of AGEs in
adipose aging remains elusive. We show a novel pro-adipogenic
function of AGEs in replicative senescent preadipocytes and
mouse embryonic fibroblasts, as well as primary preadipocytes
isolated from aged mice. Using glycated bovine serum albumin
(BSA) as a model protein of AGEs, we found that glycated BSA
restores the impaired adipogenic potential of senescent preadipocytes in vitro and ex vivo. However, glycated BSA showed no
effect on adipogenesis in nonsenescent preadipocytes. The
AGE-induced receptor for AGE (RAGE) expression is required
for the pro-adipogenic function of AGEs in senescent preadipocytes. RAGE is required for impairment of p53 expression and
p53 function in regulating p21 expression in senescent preadipocytes. We also observed a direct binding between RAGE and
p53 in senescent preadipocytes. Taken together, our findings
reveal a novel pro-adipogenic function of the AGE-RAGE axis in
p53-regulated adipogenesis of senescent preadipocytes, providing new insights into aging-dependent adiposity by diet-driven
and/or endogenous glycated proteins.

Preadipocytes from aged adipose tissue display impaired adipogenic potential and increased pro-inflammatory cytokine
secretion (1, 2). This is accompanied by cellular senescence of
preadipocytes as evidenced by increased levels of senescence-

associated ␤-galactosidase (SA-␤-gal)2 activity, reactive oxygen
species (ROS), and p53, a tumor suppressor protein, expression
(3), suggesting a positive correlation between senescence of
preadipocytes and adipose dysfunction. Analogous to aged
preadipocytes, the preadipocytes isolated from obese animals
and humans appear to exhibit senescence-like phenotypes and
impaired adipogenic potential with elevated sensitivity to
inflammatory cytokine-induced macrophage-like phenotypes
(3–7). Although understanding the precise role of senescent
preadipocytes in adipose aging still warrants further investigation, facilitated conversion of senescent preadipocytes to adipocytes appears to contribute to adipose development during
aging.
AGEs are a heterogeneous group of macromolecules that are
formed by nonenzymatic glycation of proteins, lipids, or nucleic
acids (7). Although exogenous AGEs are mainly generated during tobacco smoking and the Maillard reaction (a nonenzymatic browning reaction between amino acids and reducing
sugars mostly in heat-processed foods), endogenous AGEs are
formed through the interaction between proteins and glucose
derivatives, such as methylglyoxal and glyoxal in circulation.
Endogenous AGEs are virtually formed in all tissues, particularly during hyperglycemic conditions (8). Excess AGE intake
and chronic accumulation of AGE-related glycated proteins in
tissues are suggested to further potentiate the aging process
resulting in impaired mitochondrial function and decreased life
span in Caenorhabditis elegans and mice (9 –11). Glycated proteins are largely known to interact with an AGE-interacting
pattern recognition receptor known as RAGE. An AGE-RAGE
axis contributes to aging-associated inflammation, oxidative
stress, and the development of some of the chronic diseases
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such as atherosclerosis (12), diabetes complications, and
Alzheimer disease (13). In addition, AGEs in high fat diets are
shown to potentiate high fat diet-induced metabolic and
inflammatory disorders such as obesity, insulin resistance, and
cardiac disease (14, 15). Conversely, reduction of AGE intake (9,
10), inhibition of AGE formation (15, 16), or alleviation of
RAGE expression and function (17–20) was suggested to be an
effective approach to attenuate AGE-RAGE axis-associated
metabolic and inflammatory disorders. However, the precise
role of the AGE-RAGE axis in adipose tissue development during aging is unknown.
Here, we found that exogenous AGEs were able to restore the
adipogenic potential of replicative senescent preadipocytes,
whereas AGEs showed no effect on adipogenesis of young preadipocytes. This is through AGE-induced RAGE expression and
its interaction with p53, thereby abrogating senescence-associated p53 function in preadipocytes. These results reveal a novel
pro-adipogenic function of AGEs in adipose aging in which the
AGE-RAGE axis modulates the function of senescence-induced p53, resulting in restoring the impaired adipogenic
potential of aged adipose tissue.

EXPERIMENTAL PROCEDURES
Materials and Reagents—Bovine serum albumin (BSA) as
well as methylglyoxal (MG) (21) were purchased from MP Biomedicals, and glyceraldehyde (GA) was from Sigma. Insulin,
dexamethasone, 3-isobutyl-1-methylxanthine, propidium
iodide, and RNase A were purchased from Sigma. Fetal bovine
serum (FBS) was purchased from PAA (Dartmouth, MA). Dulbecco’s modified Eagle’s medium (DMEM), penicillin/streptomycin, and sodium pyruvate were from VWR (Radnor, PA).
TRIzol威 reagent and SuperScriptII were purchased from Invitrogen. A protein assay kit was obtained from Bio-Rad.
AGE Preparation—Twenty mg/ml of BSA dissolved in 0.2%
(w/v) Na3N containing phosphate-buffered saline (PBS) was
incubated with 100 mM MG or 100 mM GA at 37 °C for 6 days to
generate MG-BSA or GA-BSA, respectively. The glycated BSA
(i.e. MG-GSA and GA-BSA) was then filtered through a filter
with a pore size of 0.22 m followed by dialysis at 4 °C against
water to remove any free form of MG or GA. The glycated BSA
was then aliquoted and stored at ⫺20 °C.
Preadipocyte Culture and Differentiation—3T3-L1 preadipocytes were purchased from American Type Culture Collection (ATCC, Manassas, VA). Cells were cultured and differentiated as described previously (22). Replicative senescence of
3T3-L1 preadipocytes was introduced by performing a serial
passaging of 70 – 80% confluent cells. To determine the effect of
BSA or glycated BSA on adipogenesis of 3T3-L1 cells, BSA,
MG-, or GA-BSA was either added during the course of adipogenesis or at day ⫺2 to day 0 prior to the initiation of adipogenesis. In a RAGE neutralization study, 10 g/ml anti-RAGE antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA) was
added to the differentiating 3T3-L1 cells from day 0 to day 2. To
examine the effect of inhibition of p53 function on adipogenesis
of senescent 3T3-L1 preadipocytes, cells were pretreated with
the indicated concentrations of pifithrin-␣ (Calbiochem) and
BSA or glycated BSA at day ⫺3 to day ⫺2 and day ⫺2 to day 0,
respectively, prior to the initiation of adipogenesis. The lipids
DECEMBER 28, 2012 • VOLUME 287 • NUMBER 53

accumulated in differentiated preadipocytes at day 8 were
stained with Oil Red O (ORO) as described previously (22, 23).
Mouse Embryo Fibroblasts (MEFs), Primary Stromal Vascular (SV) Cell Culture, and Animal Study—MEFs purchased
from ATCC were cultured in 10% FBS/DMEM with 1% penicillin/streptomycin. Passage numbers of 1–2 and 7–10 were
considered as LP and HP, respectively. The cells were differentiated to adipocytes as described previously (24). Inguinal and
epididymal adipose tissues were dissected from 6-week-old and
1-year-old chow diet-fed male C57BL/6N mice for the study in
Fig. 1H and 14-week-old chow diet-fed or high fat diet (60%
calories from fat)-fed mice for the studies in Fig. 1I. Twelveweek-old and 1-year-old chow diet-fed male C57BL/6N mice
were used for the studies in Fig. 3, C and D. All procedures were
approved by Purdue University Animal Care and Use Committee. Primary adipose tissues isolated from these mice were
digested with collagenase to isolate the SV fraction as described
previously (25). The SV fraction containing primary preadipocytes was cultured in 10% FBS/DMEM, and subjected to adipogenesis in 10% FBS/DMEM containing 1 g/ml insulin, 5 M
dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and 2.5
g/ml rosiglitazone for 3 days, followed by incubation in 10%
FBS/DMEM supplemented with 1 g/ml insulin for 5 days.
SA-␤-gal Staining—3T3-L1 cells fixed with 3.7% formaldehyde overnight at 4 °C were incubated with freshly prepared
staining buffer (pH 6.0, 150 mM NaCl, 2 mM MgCl2, 40 mM citric
acid, 5 mM sodium phosphate, 5 mM K3Fe(CN)6, and 5 mM
K4Fe(18)6) containing 1 mg/ml 5-bromo-4-chloro-indolyl-␤-Dgalactopyranoside (X-gal) (IBI Scientific, New Haven, CT) for
18 h at 37 °C. At the end of the incubation, cells were rinsed with
PBS and were photographed under bright field (26). SA-␤-galpositive cells were quantified by Quantity One 4.5 software.
Measurement of Reactive Oxygen Species—Levels of intracellular ROS in LP and HP preadipocytes were measured by loading the cells with 40 M 2⬘,7⬘-dichlorodihydrofluorescein
diacetate (DCHF-DA) (Cayman Chemical) for 30 min at 37 °C.
Intracellular DCHF-DA oxidized to fluorescent 2⬘,7⬘-dichlorodihydrofluorescein was monitored by the fluorescence microscope (Leica Microsystems). For quantification of the intracellular 2⬘,7⬘-dichlorodihydrofluorescein, cells grown in a 96-well
plate incubated with DCHF-DA for 30 min were subjected to a
fluorescence microplate reader (SpectraMax Gemini EM,
Molecular Devices) at an excitation wavelength of 485 nm and
emission of 535 nm.
Immunoblotting—3T3-L1 cells were subjected to immunoblot analysis as described previously (22). Primary antibodies
used in the study include phospho-Akt (Ser(P)-473) and total
Akt (Epitomics, Burlingame, CA), carboxymethyl lysine (CML)
(R&D system, Minneapolis, MN), p21 (Genscript, Scotch
Plains, NJ), phospho-p53 (Ser-15) (Cell Signaling, Beverly,
MA), RAGE, p53, ␤-actin, and ␣-tubulin (Santa Cruz Biotechnology), and secondary HRP-conjugated mouse and rabbit
antibodies (The Jackson Laboratory, Bar Harbor, ME). Protein
bands were detected with Pierce ECL Plus Western blotting
reagents by autoradiography. Film was scanned and processed
using the ImageJ software, version 1.45S, from National Institutes of Health, for quantification of protein band intensity by
normalization to the band intensity of ␤-actin or ␣-tubulin.
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Immunofluorescence—3T3-L1 preadipocytes were seeded on
coverslips overnight and then treated with or without glycated
BSA for 24 h. The cells were fixed with 3.7% formaldehyde for
30 min and permeabilized in 0.2% Triton-contained PBS for 20
min. One percent BSA-contained PBST solution (0.1% Tween
20 in PBS) was used for blocking, and the cells were incubated
with RAGE antibody (1:50). Primary antibody binding was
detected using a fluorescein-conjugated secondary antibody
(Santa Cruz Biotechnology). 4⬘-6-Diamidino-2-phenylindole
(DAPI) (Calbiochem) was used for nuclear staining. RAGE and
DAPI signals from the cells were visualized by LSM 710 confocal microscopy (Carl Zeiss, Inc.).
Immunoprecipitation—To examine the interaction between
RAGE and p53, 3T3-L1 cells treated with BSA or glycated BSA
were lysed with radioimmunoprecipitation assay buffer. RAGE
and p53 in cell lysates were incubated with 2 g of anti-RAGE
and anti-p53 antibody, respectively, or control IgG at 4 °C for
1 h, followed by immunoprecipitation with protein A/G PLUSagarose beads (Santa Cruz Biotechnology) for 30 min at 4 °C.
The beads were washed with cold PBS four times and boiled
with the sample buffer (60 mM Tris, pH 6.8, 10% glycerol, 2%
SDS, 0.1% bromphenol blue, and 0.1 M dithiothreitol) for SDSPAGE and immunoblot analysis with the indicated antibodies.
Chromatin Immunoprecipitation (ChIP)—ChIP was performed as described previously (27) with some modifications.
3T3-L1 cells were cross-linked with formaldehyde at 1.5% in
PBS for 15 min and neutralized with 125 mM glycine. The nuclei
extracted from these cells were subjected to sonication to produce the chromatin fragments from 200 to 1,000 bp 5⫻ with
20-s bursts using the sonifier W-150 type (G. Heinemann, Germany). For chromatin preparation, the isolated nuclei were
precleared with 20 l of protein A/G PLUS-agarose beads for
30 min at 4 °C. 2% of the chromatin solution was used as “input”
in Fig. 5, and the remainder was incubated with p53 antibody (2
g) or a control IgG overnight at 4 °C. The immune complexes
were then recovered by incubating with 40 l of protein A/G
PLUS-agarose beads for 2 h at 4 °C. The complexes were then
subjected to 1% SDS, 100 mM NaHCO3, and 200 mM NaCl overnight at 67 °C to reverse cross-linking. DNA was then purified
using a PCR purification kit (Qiagen Inc., Chatsworth, CA) and
was subjected to reverse transcription (RT)-PCR analysis to
amplify mouse p21 promoter sequences (⫺2927 to ⫺2595)
using a primer set as follows: forward, 5⬘-CGG AGA CCA GCA
GCA AAA TCG-3⬘, and reverse, 5⬘-TGA CAC ATA CAC ACC
CC AGG CAC-3⬘ (28).
PCR Analyses—Total mRNAs from cells or tissues were
extracted with TRIzol威 (Invitrogen). The cDNA was synthesized by SuperScriptII system. A real time PCR was performed
using a SYBR premixed Taq reaction mixture in a thermocycler
(Applied Biosystems, Foster City, CA). Values were normalized
by ␤-actin expression. Data were analyzed using the ⌬⌬CT
method. RT-PCR was performed using MJ Mini Personal Thermal Cycler (Bio-Rad). The sequences of primers used in real
time PCR were as follows: PPAR␥ (forward, 5⬘-CCC AAT GGT
TGC TGA TTA CAA AT-3⬘, and reverse, 5⬘-CTA CTT TGA
TCG CAC TTT GGT ATT CT-3⬘); C/EBP␣ (forward, 5⬘-GGT
TTA GGG ATG TTT GGG TTT TT-3⬘, and reverse, 5⬘-AAG
CCC ACT TCA TTT CAT TGG T-3⬘); C/EBP␤ (forward,
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5⬘-AGC GGC TGC AGA AGA AGG T-3⬘, and reverse, 5⬘-GGC
AGC TGC TTG AAC AAG TTC-3⬘); FAS (forward, 5⬘-GCC
ACC CAC CGT CAG AAG-3⬘, and reverse, 5⬘-TGT CAC ATC
AGC CAC TTG AGT GT-3⬘); adiponectin (forward, 5⬘-GAT
GCA GGT CTT CTTG GTC CTA A-3⬘, and reverse, 5⬘-GGC
CCT TCA GCT CCT GTC A-3⬘); IL-6 (forward, 5⬘-TCG GAG
GCT TAA TTA CAC ATG TTC-3⬘, and reverse, 5⬘-TGC CAT
TGC ACA ACT CTT TTC T-3⬘); RAGE (forward, 5⬘-AAC
ACA GCC CCC ATC CAA-3⬘, and reverse, 5⬘-GCT CAA CCA
ACA GCT GAA TGC-3⬘); p53 (forward, 5⬘-GCT GCC CCC
ACC ATG AG-3⬘, and reverse, 5⬘-AAT TTC CTT CCA CCC
GGA TAA-3⬘); p21 (forward, 5⬘-AAT TGG AGT CAG GCG
CAG AT-3⬘, and reverse, 5⬘-TCC TGT TTA CCC CAG CTC
TGA A-3⬘); ␤-actin (forward, 5⬘-AGA TGA CCC AGA TCA
TGT TTG AGA-3⬘, and reverse, 5⬘-CAC AGC CTG GAT GGC
TAC GT-3⬘). The sequences of primers used in RT-PCR were
as follows: PPAR␥ (forward, 5⬘-CCA CCA ACT TCG GAA
TCA GCT-3⬘, and reverse, 5⬘-CTA CTT TGA TCG CAC TTT
GGT ATT CT-3⬘); FAS (forward, 5⬘-ACC ACT GCA TTG
ACG GCC GG-3⬘, and reverse, 5⬘-GGG TCA GGC GGG AGA
CCG AT-3⬘); adiponectin (forward, 5⬘-GGC CGT TCT CTT
CAC CTA CG-3⬘, and reverse, 5⬘-AGA TGG AGG AGC ACA
GAG CC-3⬘); RAGE (forward, 5⬘-CAG GGT CAC AGA AAC
CGG-3⬘, and reverse, 5⬘-ATT CAG CTC TGC ACG TTC
CT-3⬘); ␤-actin (forward, 5⬘-TGA CGG GGT CAC CCA CAC
TGT GCC CAT CTA-3⬘, and reverse, 5⬘-CTA GAA GCA TTT
GCG GTG GAC GAT GGA GGG-3⬘).
Lentiviral Transduction—A lentivirus-based shRNA transfer
plasmid (pLKO.1) was a gift from Dr. Xiaoqi Liu (Purdue University). All the procedures were described previously (29). The
targeting sequence of mouse RAGE (GenBankTM accession
number NM_07425) is GGG AAG GAG GTC AAG TCC AAC.
To generate lentivirus, 293T cells were co-incubated with 4 g
of pLKO.1-RAGE, 4 g of pHR⬘-CMV-R8.20vpr, and 2 g of
pHR⬘-CMV-VSV-G using Lipofectamine 2000 reagents (Invitrogen). 24 h post-transfection, viruses were then harvested
every 12 h until 72 h. The harvested media containing virus
particles were filtered though a 0.45-m pore size filter and
centrifuged at 170,000 rpm for 90 min. 3T3-L1 cells were
infected with the viral pellets in the presence of 10 g/ml Polybrene. After 24 h of viral transduction, cells were selected with
1 mg/ml puromycin for at least 3 days.
Statistical Analysis—All data are presented as means ⫾ S.E.
Statistical analysis was performed using SAS 9.0 software. Oneway analysis of variance was used to determine significance of
treatment effect and interactions. Significant differences
between group means were assessed by Dunnett’s multiple
comparison. p ⬍ 0.05 was considered significant.

RESULTS
RAGE Expression Positively Correlates with Replicative
Senescence-impaired Adipogenesis in Vitro, Adipose Tissue
Aging, and Obesity—Preadipocytes in adipose tissue from aged
animals and humans have been shown to have impaired adipogenic potency (1, 30). Because continuous cell division is known
to promote replicative senescence of cells in vitro (31–33), we
first examined the effect of replicative senescence on the adipogenic ability of 3T3-L1 murine preadipocytes and their cellular
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FIGURE 1. Replicative senescence-impaired adipogenic potential of
3T3-L1 preadipocytes and a positive correlation of AGE-RAGE axis with
adipose tissue aging and adiposity. A, ORO staining of differentiated
3T3-L1 preadipocytes (Pre) with different passage numbers (e.g. p.5, p.10, and
p.15) for 8 days. B, gene expression analysis of adiponectin and PPAR␥ in differentiated preadipocytes with passage number of ⱕ5 (LP) and ⱖ15 (HP) by
real time PCR. C, SA-␤-galactosidase activity assay in LP and HP 3T3-L1 preadipocytes as shown in the overall view (top panel) and microscopic image
(middle panel, ⫻100 magnification) and quantification of SA-␤-gal-positive
cells (bottom panel). D, real time PCR analysis of mRNA levels of p53 and IL-6 in
LP and HP preadipocytes. E, levels of ROS in LP and HP preadipocytes were
detected by DCHF-DA assay. The fluorescent signals in these cells were
viewed by fluorescence microscopy (top panel, ⫻100 magnification) and
quantified by a fluorescence microplate reader (bottom panel). F, LP and HP
3T3-L1 preadipocytes were treated with or without 167 nM insulin for 30 or 60
min. The levels of phosphorylated Akt (p-Akt(Ser473)), total Akt, and ␤-actin in
these cells were analyzed by immunoblot assay. G, RT-PCR analysis of RAGE,
adiponectin, and PPAR␥ in preadipocytes (D0) and differentiated adipocytes
(D9) of LP and HP 3T3-L1 cells. H, immunoblot analysis of inguinal fat pad
isolated from 6-week-old and 1-year-old chow diet-fed male mice (left panel),
and quantification of intensity of the major CML-modified protein (⬃55 kDa)
and RAGE and p53 bands (right panel). I, immunoblot analysis of epididymal
fat pads isolated from 14-week-old chow diet-fed lean and high fat diet-fed
obese male mice (left panel) and quantification of intensity of the major CML
modified protein (⬃55 kDa) and RAGE and aP2 bands (right panel). J, real time
PCR analysis of RAGE in epididymal fat pads isolated from lean and obese
mice. Bars represent mean ⫾ S.E. (n ⫽ 3–5). *, p ⬍ 0.05; **, p ⬍ 0.01; ***, p ⬍
0.001. All experiments were repeated at least 2–3 times.

senescence by measuring the levels of SA-␤-gal activity, mRNA
levels of p53 and IL-6, and ROS production. Preadipocytes at
passage number 15 (high passage (HP)) showed impaired adipogenesis as judged by ORO staining (Fig. 1A) and quantitative
analysis of adipocyte marker gene expressions such as adiponectin and PPAR␥ (Fig. 1B) when compared with those from
adipocytes at passage number 5 (low passage (LP)). The
impaired adipogenesis of HP preadipocytes was correlated with
DECEMBER 28, 2012 • VOLUME 287 • NUMBER 53

delayed cell cycle progress during the mitotic clonal expansion
of adipogenesis (data not shown). Moreover, these HP cells displayed a significant increase in SA-␤-gal activity (Fig. 1C) and
mRNA levels of p53 and IL-6 (Fig. 1D) compared with those
from LP preadipocytes. Replicative senescence of 3T3-L1 preadipocytes is associated with enhanced ROS production (Fig. 1E)
and impaired insulin-induced Akt phosphorylation (Fig. 1F).
These results collectively suggested that a serial passage in
3T3-L1 preadipocytes yields senescent characteristics with
impaired adipogenic potential in vitro. The RAGE gene has
been reported to be expressed in various tissues such as mouse
bone marrow in an aging-dependent manner (34). In addition,
aging is reported to be positively associated with accumulation
of AGEs. AGEs have the intrinsic fluorescence (i.e. pentosidine)
and are chemically characterized by modification of lysine residues primarily to CML (35, 36). To further examine whether
the AGE-RAGE axis is associated with adipose aging, we next
measured the levels of intracellular AGEs, as judged by detecting the presence of CML-modified proteins and/or RAGE in
senescent adipocytes and adipose tissue isolated from aged or
obese mice. Differentiated HP senescent preadipocytes exhibited a higher level of RAGE than that in LP adipocytes with
reduced levels of adiponectin and PPAR␥ compared with those
in LP adipocytes (Fig. 1G). Similarly, elevated levels of the
CML-modified proteins RAGE and p53 were also observed in
the inguinal fat pads isolated from 1-year-old mice compared
with those in 6-week-old chow-fed mice (Fig. 1H). Moreover,
high fat diet-induced obese mice displayed elevated levels of
CML-modified proteins, RAGE and aP2, an adipocyte marker
protein, in epididymal fat pads compared with those in lean
mice (Fig. 1I), as well as RAGE mRNA (Fig. 1J). Overall, our
results indicate that a serial passage in 3T3-L1 preadipocytes is
associated with development of senescent characteristics. Furthermore, adipose aging and obesity appear to be correlated
with an elevated level of AGE-RAGE interaction.
Glycated BSA Restores Impaired Adipogenic Potential of
Senescent Preadipocytes—To examine the effect of AGEs on the
adipogenic potential of senescent preadipocytes, we first
exposed senescent preadipocytes to glycated BSA during adipogenesis as depicted in Fig. 2A. Glycated BSA generated by
incubation of BSA with glucose derivatives such as MG and GA
is fluorescent, a characteristic of AGEs (37), and this has been
used as in vitro model of AGEs in many studies (38, 39). Both
BSA and glycated BSA, such as MG-BSA and GA-BSA at the
concentration of 300 g/ml, showed no additional effect on
adipogenesis of LP preadipocytes as judged by both ORO (Fig.
2A, middle panel) and quantification of ORO stained lipids (Fig.
2B). Consistent with Fig. 1A, senescent HP preadipocytes failed
to differentiate when the cells were treated with BSA during 8
days of adipogenesis (Fig. 2A). Interestingly, treatments of
senescent HP preadipocytes with 300 g/ml MG-BSA or GABSA resulted in ⬃2.5- and 3.5-fold induction of intracellular
lipid droplet accumulation, respectively, compared with BSAtreated control cells (Fig. 2, A and B). In accordance with
increased lipid accumulation, senescent HP preadipocytes differentiated in the presence of MG-BSA or GA-BSA showed
dramatically increased levels of adipocyte marker genes such as
PPAR␥, C/EBP␣, adiponectin, FAS, and leptin (Fig. 2C) as well
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Glycated BSA promotes adipogenesis of senescent preadipocytes. A, schematic of BSA or glycated BSA (MG- and GA-BSA, 300 g/ml)
treatment of LP and HP 3T3-L1 preadipocytes during an 8-day of adipogenesis (top panel). Representative ORO-stained images of these cells (bottom
panel). B, quantification of ORO-stained 3T3-L1 cells in A. Real time PCR analysis (C) and RT-PCR analysis (D) of genes in HP preadipocytes differentiated in
the presence or absence of 300 g/ml BSA or glycated BSA. Bars represent
mean ⫾ S.E. (n ⫽ 3). *, p ⬍ 0.05; **, p ⬍ 0.01; ***, p ⬍ 0.001. All experiments
were repeated at least 2–3 times.

as RAGE mRNA (Fig. 2D). However, glycated BSA showed no
effect on C/EBP␤ in differentiated HP preadipocytes (Fig. 2C).
We next examined whether pre-exposure of senescent HP
preadipocytes to glycated BSA is necessary for restoring the
impaired adipogenic potential of senescent preadipocytes. As
depicted in Fig. 3A, a 48-h pretreatment (i.e. day ⫺2 to day 0) of
HP preadipocytes with MG-BSA or GA-BSA resulted in an
increase of lipid droplet accumulation after 8 days of differentiation. We further confirmed the pro-adipogenic function of
glycated BSA in replicative senescent MEF cells and cells in the
SV fraction of adipose tissues isolated from mice of different
ages, such as 12 weeks old and 1 year old. Although LP MEF
cells (i.e. passage 1–2) were normally differentiated with accumulated lipid droplets regardless of the treatments, HP MEF
cells (i.e. passage 7–10) showed impaired adipogenesis as
judged by ORO staining, and this impaired adipogenic ability
was restored when the HP MEF cells were pretreated with MGBSA or GA-BSA for 48 h prior to induction of adipogenesis (Fig.
3B). Furthermore, 1-year-old primary inguinal SV cells pretreated with MG-BSA or GA-BSA for 48 h resulted in accumulation of lipid droplets after 8 days of adipogenesis, whereas
glycated BSA showed no effect on adipogenesis in primary
inguinal SV cells isolated from 12-week-old mice as judged by
ORO staining (Fig. 3C) and gene expression analysis adipocyte
markers such as PPAR␥, adiponectin, and FAS (Fig. 3D). Collectively, these results supported the hypothesis that AGEs
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restore the adipogenic potential of aged preadipocytes both in
vitro and ex vivo.
RAGE Is Required for the Pro-adipogenic Effect of Glycated
BSA in Senescent Preadipocytes—Our findings of the glycated
BSA-restored adipogenic potential of senescent preadipocytes
with an elevated level of RAGE led us to hypothesize that RAGE
mediates AGE-induced adipogenesis in senescent preadipocytes. To test this, we first confirmed the effect of glycated
BSA on the protein levels of RAGE in HP preadipocytes. We
found that senescent HP preadipocytes treated with MG-BSA
or GA-BSA for 48 h displayed an ⬃2- or 3-fold increase in
RAGE level, respectively (Fig. 4A, left panel). Immunofluorescence of glycated BSA-treated HP preadipocytes further confirmed induction of RAGE by glycated BSA detected predominantly in the cytoplasm and nucleus (Fig. 4A, right panel). We
next investigated whether the increase in RAGE by glycated
BSA is required for AGE-induced adipogenesis in HP preadipocytes. To ascertain this, we utilized neutralizing antibody
against RAGE. We found that glycated BSA-induced adipogenesis of senescent HP preadipocytes was blunted by neutralizing
the antibody against RAGE (Fig. 4B). Moreover, a lentiviral
knockdown of RAGE mRNA in senescent HP preadipocytes as
confirmed by PCR (Fig. 4C, left panel) and immunoblot (Fig.
4C, right panel) analyses abrogated glycated BSA-induced adipogenesis in senescent HP 3T3-L1 cells (Fig. 4D) with reduced
levels of PPAR␥ and FAS after 8 days of differentiation (Fig. 4E).
These findings suggested that RAGE is required for AGE-induced restoration of the adipogenic potential of senescent
preadipocytes.
AGE-activated RAGE Binds to p53 and Inhibits p53 Expression in Senescent Preadipocytes—Given that a tumor suppressor p53 has been shown to modulate adipose tissue function
and senescence (40), we attempted to examine whether p53
modulates AGE-RAGE-induced adipogenesis in senescent
preadipocytes. First, we examined the effect of glycated BSA on
the protein levels of p53 and p21, a downstream target of p53, in
HP preadipocytes. As expected, senescent HP preadipocytes
treated with glycated BSA showed an increase in RAGE (Fig.
5A). This was accompanied by reduced levels of p53 and phosphorylated p53 (Fig. 5A), suggesting a suppressive role of glycated BSA in p53 expression in senescent preadipocytes. We
next investigated whether RAGE expression is required for glycated BSA-suppressed protein levels of p53 and p21 in senescent preadipocytes. As shown in Fig. 5A, a lentiviral knockdown
of RAGE in senescent preadipocytes reversed glycated BSAsuppressed total and phosphorylated forms of p53 and p21.
Consistent with this, glycated BSA also suppressed mRNA levels of p53 and p21 in control senescent preadipocytes, whereas
this was reversed in MG- or GA-BSA-treated RAGE knockdown senescent preadipocytes (Fig. 5B). Apparently, glycated
BSA-suppressed p21 expression was through altered DNA
binding ability of p53 to the promoter region of p21 in MG- or
GA-BSA-treated control senescent preadipocytes as judged by
ChIP assay (Fig. 5C). However, RAGE knockdown resulted in
increased DNA binding ability of p53 to the p21 promoter in
both BSA- and glycated BSA-treated senescent preadipocytes
(Fig. 5D). Because our finding in Fig. 4A demonstrated the presence of RAGE in the cytosolic space of senescent preadipocytes,
VOLUME 287 • NUMBER 53 • DECEMBER 28, 2012
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FIGURE 3. Pretreatment of glycated BSA leads to an induction of adipogenesis in senescent HP 3T3-L1 preadipocytes, MEF, and inguinal SV cells. A,
schematic of glycated BSA (MG- and GA-BSA, 300 g/ml) pretreatment of HP 3T3-L1 preadipocytes prior to an 8-day adipogenesis (top panel). Representative
ORO-stained image (middle panel) and quantification of ORO-stained HP adipocytes pretreated with BSA or glycated BSA (bottom panel) are shown. Representative microscopic image of ORO-stained LP (passage number 2) and HP (passage number 7) MEF cells (B) and primary SV cells isolated from inguinal fat
pads of 12-week-old and 1-year-old chow diet-fed male mice (C) were pretreated with BSA or glycated BSA prior to induction of adipogenesis. Cells were then
stained with ORO and subjected to microscopic imaging (⫻100 magnification). D, RT-PCR analysis of differentiated inguinal SV cells in C. Bars represent mean ⫾
S.E. (n ⫽ 3). **, p ⬍ 0.01; ***, p ⬍ 0.001.

we further sought the direct binding between RAGE and p53,
and the effect of glycated BSA on the RAGE-p53 binding. Our
immunoprecipitation assay revealed a physical interaction
between RAGE and p53 in senescent preadipocytes, and this
was not affected by the treatment with glycated BSA (Fig. 5D).
Consistent with our finding of AGE-impaired p53 function in
senescent preadipocytes, differentiating senescent preadipocytes pretreated with different concentrations of pifithrin-␣,
a p53 inhibitor, for 24 h followed by a 48-h treatment with
glycated BSA prior to the initiation of adipogenesis resulted in a
dose-dependent increase in adipogenesis as judged by ORO
staining (Fig. 5E). Overall, our results indicate that AGERAGE-induced adipogenesis in senescent preadipocytes is
through AGE-dependent impairment of p53 expression and
p53 function in senescent preadipocytes. Interestingly, we also
demonstrated a direct interaction between RAGE and p53 in
senescent preadipocytes, but its role in adipogenesis and the
function of senescent preadipocytes still remain elusive.

DISCUSSION
Senescent preadipocytes are known to exhibit reduced replicative and adipogenic capacity, increased pro-inflammatory
responses, and susceptibility to lipotoxicity during aging (3).
Much of our current understanding of the biological function of
AGEs has been largely limited to their actions in diabetic and
cardiovascular complications during aging through AGERAGE-induced oxidative stress and inflammation (41, 42). The
AGE-RAGE pathway has been shown to be associated with
aging of humans and animals (14, 43), as well as the cellular
differentiation program of various cell types (44, 45). Moreover,
RAGE has shown to participate in high fat diet-induced
DECEMBER 28, 2012 • VOLUME 287 • NUMBER 53

complications such as cardiac inflammation (15), atherosclerosis (46), renal implication (17) with potential adiposity.
However, the role of the AGE-RAGE axis in adipose aging
remains unknown.
Here, we report a novel function of AGEs in restoring
impaired adipogenic potential of senescent preadipocytes
through RAGE-dependent modulation of p53 function via
RAGE-dependent suppression of p53 and possibly by a physical
interaction between RAGE and p53 as depicted in Fig. 6. Our
findings thus infer that senescent preadipocytes are likely to
resume adipogenesis when these cells are exposed to dietdriven exogenous and endogenously generated glycated proteins through altered p53 expression and function, thereby
impacting adipose development during aging.
A number of intriguing questions have been brought forth by
our findings. First, mechanisms by which RAGE, a membranebound protein, is found in the cytosol and interacts with p53 in
senescent preadipocytes should be determined. Although most
of the predicted and experimentally tested proteolytic cleavage
sites in RAGE are found in the extracellular domain to generate
soluble forms of RAGE, it has been reported to also be detected
in the intracellular space in various cell types such as muscle
satellite cells, astrocytes, and amyloid-␤-stimulated murine
cortical neuron (47– 49). Increasing evidence points to the role
of proteolytic cleavage in regulating the function of RAGE isoforms in both the extracellular and intracellular space (50).
Interestingly, aging-dependent truncation of RAGE and its
detection in the cytosol of human muscle satellite cells has been
reported (47). Moreover, generation of the truncated form of
RAGE in aged human muscle satellite cells appears to be
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 4. RAGE is required for AGE-induced adipogenesis in senescent
preadipocytes. A, immunoblot analysis (top left panel) and quantification
(bottom left panel) of RAGE in LP and HP 3T3-L1 preadipocytes exposed to BSA
(300 g/ml) or MG-BSA or GA-BSA (300 g/ml) for 48 h. Immunofluorescent
images of RAGE (green) and DAPI-stained nucleus (blue) of HP 3T3-L1 preadipocytes treated with or without 300 g/ml BSA, MG-BSA, or GA-BSA for 48 h
(right panel). Scale bars, 20 m. B, ORO staining (left panel) and quantitative
ORO staining analyses (right panel) of HP 3T3-L1 preadipocytes differentiated
for 8 days after pretreatment with 300 g/ml BSA or glycated BSA from day
⫺2 to day 0 in the presence or absence of 10 g/ml anti-RAGE antibody. C, HP
3T3-L1 preadipocytes infected with control lentivirus (sh-Control) or lentivirus
containing RAGE-specific shRNA (sh-RAGE) for 24 h were subjected to RT-PCR
analysis of RAGE mRNA (left panel). Immunoblot analysis of RAGE in lentivirusinfected HP 3T3-L1 preadipocytes treated with 300 g/ml BSA, MG-BSA, or
GA-BSA for 48 h (right panel). Lentivirus-infected HP preadipocytes were pretreated with 300 g/ml BSA, MG-BSA, or GA-BSA for 48 h followed by an 8-day
adipogenesis. These cells were subjected to ORO staining analysis (D) and real
time PCR analysis of RAGE, PPAR␥, and FAS (E). Pre, preadipocytes; Adipo, adipocytes; N.S., not significant. Bars represent mean ⫾ S.E. (n ⫽ 3). *, p ⬍ 0.05; **,
p ⬍ 0.01; ***, p ⬍ 0.001. #, p ⬍ 0.05 versus BSA. All experiments were repeated
at least 2–3 times.

dependent on proteosomal activity. Thus, it would be plausible
to assume that AGE-induced binding between RAGE and p53
in senescent preadipocytes is likely through AGE-dependent
proteolytic cleavage of RAGE by not-yet-known mechanism(s).
More studies are necessary to test this hypothesis.
Second, although the understanding of the mechanism
underlying AGE-RAGE axis-regulated p53 expression and p53
function in senescent preadipocytes remains elusive, accumulated evidence suggests an important role for RAGE and p53 in
cell proliferation and senescence. An inhibitory function of
RAGE in p53 expression and p53 function has been reported in
tumor and osteoblastic cells (51, 52). In line with this, RAGE has
been recently proposed to regulate both autophagy and apoptosis (53–55). Additionally, RAGE knockdown has been shown to
lower degradation and ubiquitination of p53, thereby promoting its nuclear translocation in murine osteoblastic cells (52).
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On the one hand, p53 has been known to inhibit adipogenesis
and to be involved in maintaining the proper function of the
adipose tissue (56) and 3T3-L1 cells (57), possibly through suppression of the key adipogenic transcriptional factor such as
PPAR␥ (58). On the other hand, activated p53 is known to be
involved in the development of early aging in adipose tissue
with reduced adipose tissue deposition and adipose inflammation in animals (23, 60, 61). p53 appears to modulate adipose
aging because inhibition of p53 function in adipose tissue has
been reported to suppress senescence-like phenotypes with
improved insulin sensitivity (61). Collectively, these studies
indicate that future study should be directed to understanding
the role of RAGE in p53-dependent cross-talk between
autophagy and apoptosis in adipose aging. It should also be
noted that RAGE knockdown in senescent preadipocytes
resulted in a slight increase in p53 protein (Fig. 5A) but a
decrease in p53 mRNA (Fig. 5B) in the absence of glycated BSA
treatment. Although more studies are needed to address this
discrepancy, this result suggests a possibility of the potential
role of RAGE in regulating p53 protein stability.
Nevertheless, our findings define a novel pro-adipogenic
function of AGEs in senescent preadipocytes. Although our
study is largely based on in vitro and ex vivo studies, we would
predict that a chronic dietary intake of AGEs would positively
contribute to adipose development during aging. Serum AGE
levels in humans appear to be influenced by diet-driven AGE
intake. For example, administration of single AGE-rich diet
resulted in an increase in serum AGE levels from ⬃10 to 80
units/ml in normal subjects and to ⬃120 units/ml in diabetic
subjects after several h of ingestion, where 1 unit is defined to be
equivalent to ⬃10 g of CML-BSA (62). Accordingly, serum
AGEs levels found in this study would be in the range of 0.8 –1.2
mg/ml glycated BSA. In addition, Sandu et al. (14) reported that
normal mice fed a high fat diet containing 995.4 units/mg AGEs
for 6 months resulted in elevation of AGE levels in the serum
and adipose tissue at 124 ⫾ 7 units/ml and 400 units/mg (i.e.
⬃1.24 mg of CML-BSA/ml and ⬃4 mg of CML-BSA/mg),
respectively. Supporting this notion, a recent study demonstrated that mice fed a standard chow diet supplemented with 1
mg of MG-BSA/g of diet for 18 months showed elevated AGE
levels in the serum as well as in adipose tissue to 0.43 mg of
CML-BSA/ml and 190 nmol of MG/g of tissue, respectively
(63). Collectively, these studies suggest that the AGE concentration we used in our study is likely to be achievable in the sera
of humans and animals after a chronic oral administration of an
AGE-rich diet.
Recent studies showed that chronic AGE-rich standard diet
feeding studies in animals showed an increase in body weight
with no report on the change in adipose mass with elevated
insulin resistance (14, 64, 65). Conversely, a long term of feeding study of mice with AGE-restricted standard diet resulted in
reduced body weight gain with enhanced insulin sensitivity and
life span at the end of the study (66). Moreover, Monden et al.
(59) and Cai et al. (63) recently demonstrated a causative role of
dietary AGEs and RAGE expression in adiposity, and its related
insulin resistance and cellular anti-oxidant system. Cai et al.
(63) further showed that oral administration of an AGE-rich
diet promotes insulin resistance in mice by severe deficiency of
VOLUME 287 • NUMBER 53 • DECEMBER 28, 2012
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FIGURE 5. Binding between AGE-activated RAGE and p53 inhibits p53 expression in senescent preadipocytes. LP 3T3-L1 preadipocytes, control (shControl), and RAGE-knockdown (sh-RAGE) HP preadipocytes treated with or without 300 g/ml BSA or MG-BSA/GA-BSA for 48 h were subjected to immunoblot
analysis of RAGE, phosphorylated p53 (p-p53 (Ser15)) and p21 (A), and gene expression analysis of p53 and p21 (B). ChIP assay (C) and immunoprecipitation (D)
of the HP preadipocytes used in A. IP, immunoprecipitation. IB, immunoblot. E, confluent HP preadipocytes were treated with pifithrin-␣ (PFT-␣) at 0, 10, and
50 M for 24 h followed by an exposure to 300 g/ml BSA or MG-BSA/GA-BSA for additional 48 h in the absence of pifithrin-␣. These cells were subjected to
adipogenesis for 8 days. Lipid accumulation in differentiated HP preadipocytes was detected by ORO staining (left panel) and a quantitative ORO staining
analysis (right panel). Bars represent mean ⫾ S.E. (n ⫽ 3). *, p ⬍ 0.05; **, p ⬍ 0.01; ***, p ⬍ 0.001. N.S., not significant. ##, p ⬍ 0.01 and ###, p ⬍ 0.001 versus BSA.
All experiments were repeated at least 2–3 times.

pose tissue (63). Although these elegant studies clearly indicated a novel pathogenic role of AGEs and an altered RAGE
level in obesity and type 2 diabetes, the direct role of the AGERAGE axis in aging-dependent impairment of adipogenic
potential in aged preadipocytes and its contribution to agingrelated metabolic and inflammatory dysfunction are unknown.
To our knowledge, our study is the first report that AGEs are
able to restore the senescence-impaired adipogenic potential of
aged preadipocytes. These findings implicate that AGE-induced adipogenesis in senescent preadipocytes is likely to contribute to exacerbating aging-related adiposity.
In conclusion, our finding of the pro-adipogenic function of
AGE-RAGE axis in senescent preadipocytes through a mechanism by which RAGE suppresses p53 function and expression
may provide new insights into the aging-dependent adiposity
by glycated proteins derived from the diet and/or chronically
dysregulated metabolic conditions such as hyperglycemia.
FIGURE 6. Proposed function of AGE-RAGE axis in adipogenesis of senescent preadipocytes. Activated RAGE by binding with proteins glycated with
glucose derivatives in senescent preadipocytes triggers inhibition of p53
function (e.g. transcriptional activation of p21) through a direct binding to
cytosolic p53. However, the mechanism by which RAGE is released from
membrane to cytosol upon interaction with glycated proteins remains elusive. In addition, the AGE-RAGE axis results in suppression of the p53 mRNA
level in senescent preadipocytes by an unknown mechanism. The AGE-RAGE
axis-regulated p53 function and expression, in turn, allow senescent preadipocytes to restore the impaired adipogenic potential.

an anti-AGE advanced glycation receptor1 (AGER1) and SIRT1
in peripheral tissues with impaired glucose uptake, altered
insulin signaling pathway, and inflammatory activation in adiDECEMBER 28, 2012 • VOLUME 287 • NUMBER 53
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